Effects of Simvastatin on Bone Turnover and BMD: A 1‐Year Randomized Controlled Trial in Postmenopausal Osteopenic Women

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Bone and Mineral Research

• Publication date

  2004-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1359/jbmr.040209PMID 15068496
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hot Papers in the Literature

  2003cited by this paper
• Hot Papers in the Literature

  2003cited by this paper
• Effect of simvastatin treatment on bone mineral density and bone turnover in hypercholesterolemic postmenopausal women: a 1-year longitudinal study.

  2003cited by this paper
• Statins decrease bone turnover in postmenopausal women: a cross‐sectional study

  2002cited by this paper
• Lipid-lowering agents and the risk of hip fracture in a Medicaid population

  2002cited by this paper
• Statin use, bone mineral density, and fracture risk: Geelong Osteoporosis Study.

  2002cited by this paper
• Relation of Statin Use and Bone Loss: A Prospective Population-Based Cohort Study in Early Postmenopausal Women

  2002cited by this paper
• Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease.

  2001cited by this paper
• Effect of Statins on Bone Mineral Density and Bone Histomorphometry in Rodents

  2001cited by this paper
• Use of statins and risk of fractures.

  2001cited by this paper
• Statin Given Perorally to Adult Rats Increases Cancellous Bone Mass and Compressive Strength

  2001cited by this paper
• Statin drugs and the risk of fracture

  2000cited by this paper
• HMG-CoA reductase inhibitors and the risk of fractures.

  2000cited by this paper
• Oral statins and increased bone-mineral density in postmenopausal women.

  2000influential reference
• Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women.

  2000cited by this paper
• HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients.

  2000cited by this paper
• Problems in Pharmacoeconomic Analyses—Reply

  2000cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society HMG-CoA Reductase Inhibitors Increase BMD in Type 2 Diabetes Mellitus Patients*

  1999cited by this paper
• A review of the healthy worker effect in occupational epidemiology.

  1999cited by this paper
• Healthy volunteer effect in industrial workers.

  1999cited by this paper
• Stimulation of bone formation in vitro and in rodents by statins.

  1999influential reference
• The Effect of Cross-Linking on the In Vivo Disintegration of Hard Gelatin Capsules

  1998cited by this paper
• Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies.

  1995cited by this paper
• Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S).

  1995cited by this paper
• Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis.

  1993cited by this paper
• Relationship between forearm and vertebral mineral density in postmenopausal women with primary hyperparathyroidism.

  1990influential reference

• Prospective evidence for the gut-bone axis in osteoporotic fractures: Insights from genetic prediction and metabolite mediators.

  2025cites this paper
• Statins and longitudinal changes in vertebral bone mineral density in an emulated target trial: the multi-ethnic study of atherosclerosis.

  2025cites this paper
• Efficacy of Statins in Postmenopausal Osteoporosis: A Systematic Review and Meta-Analysis

  2025influential citation
• The local application of a 1% simvastatin gel improves bone regeneration in osteoporotic mandibular defects: a rat model study

  2025cites this paper
• The Effect of Statin Therapy on Bone Metabolism Markers and Mineral Density: Aa GRADE-Assessed Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials

  2024influential citation
• Efectos de los estatinas en la densidad mineral ósea de mujeres posmenopáusica de Córdoba, Argentina

  2024cites this paper
• The interplay between bone and heart health as reflected in medication effects: A narrative review

  2023cites this paper
• Influence of varying thermal treatment on bioactive material with equal Ca/P ratio: A local drug delivery system for bone regeneration.

  2022cites this paper
• Simvastatin therapy in higher dosages deteriorates bone quality: Consistent evidence from population-wide patient data and interventional mouse studies.

  2022cites this paper
• Regulation of Osteoclast Differentiation and Activity by Lipid Metabolism

  2021cites this paper
• Biochemical markers of bone turnover in osteoporosis

  2021cites this paper
• The associations of statin intake and the trabecular bone score and bone mineral density status in elderly Iranian individuals: a cross-sectional analysis of the Bushehr Elderly Health (BEH) program

  2021cites this paper
• Is Vitamin D level elevated in patients on statin treatment?

  2019cites this paper
• Adjuvant drug-assisted bone healing: Part III – Further strategies for local and systemic modulation

  2019cites this paper
• Drugs Causing Bone Loss.

  2019cites this paper
• Injectable in Situ Shape-Forming Osteogenic Nanocomposite Hydrogel for Regenerating Irregular Bone Defects.

  2018cites this paper
• Effects of treatment with an angiotensin 2 receptor blocker and/or vitamin D3 on parathyroid hormone and aldosterone: A randomized, placebo‐controlled trial

  2018cites this paper
• STATINS AND BONE HEALTH: A MINI REVIEW.

  2018cites this paper
• Association Between Cortical Bone Microstructure and Statin Use in Older Women

  2018cites this paper
• Impact of Statin Therapy on Plasma Vitamin D Levels: A Systematic Review and Meta-Analysis.

  2017cites this paper
• Statin use does not protect from fractures: the healthy adherer effect is a plausible explanation in observational studies

  2017cites this paper
• The effects of simvastatin on osseo-integration around titanium implants in posterior maxilla of osteoporotic rats

  2017cites this paper
• Benefits and Adverse Effects of Statins, Atorvastatin Calcium Hydrate,Pitavastatin Calcium, and Pravastatin Sodium, for Dyslipidemia in Patientson Hemodialysis

  2016cites this paper
• The effects of combined human parathyroid hormone (1–34) and simvastatin treatment on the interface of hydroxyapatite-coated titanium rods implanted into osteopenic rats femurs

  2016cites this paper
• Efficacy of statins for osteoporosis: a systematic review and meta-analysis

  2016cites this paper
• Wheelchair use and lipophilic statin medications may influence bone loss in chronic spinal cord injury: findings from the FRASCI-bone loss study

  2016cites this paper
• Effects of Statins on Bone Mineral Density and Fracture Risk

  2016cites this paper
• Poly(l-Lactic Acid)/Gelatin Fibrous Scaffold Loaded with Simvastatin/Beta-Cyclodextrin-Modified Hydroxyapatite Inclusion Complex for Bone Tissue Regeneration.

  2016cites this paper
• Simvastatin Encapsulation in Alginate-Based Microspheres

  2016cites this paper
• Local drug delivery for enhancing fracture healing in osteoporotic bone.

  2015cites this paper
• The relationship between bone mineral density and lipid status and anthropometric parameters in patients with dyslipidaemia

  2015cites this paper
• Novel applications of statins for bone regeneration.

  2015cites this paper
• Effect of Statin Therapy Duration on Bone Turnover Markers in Dyslipidemic Patients

  2015cites this paper
• Ameliorating effect of combination of simvastatin and residronate on glucocorticoid induced osteoporosis model in rats

  2015cites this paper
• Feasibility of self-sampled dried blood spot and saliva samples sent by mail in a population-based study

  2015cites this paper
• Simvastatin prodrug micelles target fracture and improve healing.

  2015cites this paper
• Risk factors for osteoporosis in Japan: is it associated with Helicobacter pylori?

  2015cites this paper
• Efecto de la atorvastatina en el tratamiento de la periodontitis crónica moderada

  2014cites this paper
• Effects of atorvastatin on bone mineral density (BMD) and bone metabolism in elderly males with osteopenia and mild dyslipidemia: a 1-year randomized trial.

  2014cites this paper
• The effect of simvastatin-loaded polymeric microspheres in a critical size bone defect in the rabbit calvaria.

  2014cites this paper
• Bone mineral density in statin users: a population-based analysis from a Spanish cohort

  2014cites this paper
• Statins, bone metabolism and treatment of bone catabolic diseases.

  2014cites this paper
• Effect of Simvastatin and Atorvastatin on Serum Vitamin D and Bone Mineral Density in Hypercholesterolemic Patients: A Cross-Sectional Study

  2014cites this paper
• Bone turnover markers in statin users: a population-based analysis from the Camargo Cohort Study.

  2013cites this paper
• Enhanced in vitro osteoblast differentiation on TiO2 scaffold coated with alginate hydrogel containing simvastatin

  2013cites this paper
• Biochemical Markers of Bone Turnover in Osteoporosis

  2013cites this paper
• A review on the use of statins and tocotrienols, individually or in combination for the treatment of osteoporosis.

  2013cites this paper
• HMG-CoA reductase inhibitors (statins) and bone mineral density: a meta-analysis.

  2013cites this paper
• Effects of simvastatin-loaded polymeric micelles on human osteoblast-like MG-63 cells.

  2013cites this paper
• EFFECTS OF SIMVASTATIN ON FEMORAL BIOMECHANICS IN OVARIECTOMIZED RATS

  2013cites this paper
• Serum bone formation marker correlation with improved osseointegration in osteoporotic rats treated with simvastatin.

  2013cites this paper
• Mevalonate-suppressive dietary isoprenoids for bone health.

  2012cites this paper
• High bone density and bone health.

  2012cites this paper
• Heart drugs that affect bone.

  2012cites this paper
• Effects of Tocotrienol and Lovastatin Combination on Osteoblast and Osteoclast Activity in Estrogen-Deficient Osteoporosis

  2012influential citation
• Short reviewHigh bone density and bone healthDensidad ósea elevada y salud ósea

  2012cites this paper
• REVIEWS: CURRENT TOPICS Mevalonate-suppressive dietary isoprenoids for bone health

  2012cites this paper
• Review Article: Health benefit of increased serum 25(OH)D levels from oral intake and ultraviolet-B irradiance in the Nordic countries

  2011cites this paper
• Simvastatin protects human osteosarcoma cells from oxidative stress-induced apoptosis through mitochondrial-mediated signaling.

  2011cites this paper
• Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis

  2011cites this paper
• Statins and bone health in postmenopausal women: a systematic review of randomized controlled trials

  2010cites this paper
• Local Low-Dose Lovastatin Delivery Improves the Bone-Healing Defect Caused by Nf1 Loss of Function in Osteoblasts

  2010cites this paper
• Exploring new indications for statins beyond atherosclerosis: Successes and setbacks.

  2010cites this paper
• Simvastatin induces osteogenic differentiation of murine embryonic stem cells

  2010cites this paper
• A systems approach to bone pathophysiology

  2010cites this paper
• Statins: candidates for promoting bone formation via BMP-2

  2010cites this paper
• Can low doses of simvastatin enhance fracture healing? An experimental study in rabbits.

  2009cites this paper
• A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma

  2009cites this paper
• Future of anticathepsin K drugs: dual therapy for skeletal disease and atherosclerosis?

  2009cites this paper
• Analysis of skeletal status by quantitative ultrasonometry in a cohort of postmenopausal women with high blood cholesterol without documented osteoporosis.

  2009cites this paper
• Rosuvastatin increased serum osteocalcin levels independent of its serum cholesterol-lowering effect in patients with type 2 diabetes and hypercholesterolemia.

  2009cites this paper
• Simvastatin Does Not Affect Vitamin D Status, but Low Vitamin D Levels Are Associated with Dyslipidemia: Results from a Randomised, Controlled Trial

  2009influential citation
• Effects of Simvastatin on bone healing around titanium implants in osteoporotic rats.

  2009cites this paper
• Effect of atorvastatin on bone mineral density in patients with acute coronary syndrome.

  2008cites this paper
• Cardiovascular drugs and bone.

  2008cites this paper
• Simvastatin induces estrogen receptor-alpha (ER-α) in murine bone marrow stromal cells

  2008cites this paper
• Statins: under investigation for increasing bone mineral density and augmenting fracture healing

  2008influential citation
• Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis

  2008cites this paper
• Statin-induced calcification in human mesenchymal stem cells is cell death related

  2008cites this paper
• Statins: under investigation for increasing bone mineral density and augmenting fracture healing.

  2008cites this paper
• Choline-stabilized orthosilicic acid supplementation as an adjunct to Calcium/Vitamin D3 stimulates markers of bone formation in osteopenic females: a randomized, placebo-controlled trial

  2008cites this paper
• Will Statin Use Prevent Fracture of Type 2 Diabetes Associated with Thiazolidinedione Treatment? A Mini-Review and a Hypothesis

  2008cites this paper
• Short-term effects of atorvastatin on bone turnover in male patients with hypercholesterolemia.

  2007cites this paper
• A Comparison between the Effects of Hydrophobic and Hydrophilic Statins on Osteoclast Function In Vitro and Ovariectomy-Induced Bone Loss In Vivo

  2007cites this paper
• Emerging pharmacologic therapies for osteoporosis

  2007cites this paper
• Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: a double-blind, placebo-controlled, dose-ranging trial.

  2007cites this paper
• Short-term effects of pitavastatin on biochemical markers of bone turnover in patients with hypercholesterolemia.

  2007influential citation
• Anabolic agents and the bone morphogenetic protein pathway.

  2007cites this paper
• Lovastatin effects on bone mineral density in postmenopausal women with type 2 diabetes mellitus

  2007cites this paper
• Simvastatin and atorvastatin enhance gene expression of collagen type 1 and osteocalcin in primary human osteoblasts and MG‐63 cultures

  2007cites this paper
• Locally applied simvastatin promotes fracture healing in ovariectomized rat

  2007cites this paper
• Association of lower serum cholesterol levels with higher risk of osteoporosis in type 2 diabetes.

  2007cites this paper
• Effects of statins on bone mineral density: a meta-analysis of clinical studies.

  2007influential citation
• Fracture risk associated with drugs: a search for candidate drugs in the same way as for candidate genes

  2007cites this paper
• Do cholesterol-lowering drugs influence on bone metabolism?

  2006cites this paper
• Hyperlipidemia is not Associated With Low Bone Mineral Density in Postmenopausal Obese Women

  2006influential citation
• Statin but not Non-Statin Lipid-Lowering Drugs Decrease Fracture Risk: A Nation-Wide Case-Control Study

  2006cites this paper
• Les statines en rhumatologie

  2006cites this paper
• Statins in rheumatology.

  2006cites this paper
• Statins and bone metabolism.

  2006cites this paper